Manipal Health IPO: Latest News, Date, Price, GMP, Valuation, And Should You Invest?

A name most Indians recognise, Manipal Hospitals is one of the largest hospital networks in the country. Now, the company is entering the stock market. This has created a lot of buzz among investors.

Key Takeaways

• The Manipal Health IPO opens for subscription on July 29, 2026, and closes on July 31, 2026.
• The price band is set at ₹560 to ₹590 per share.
• The IPO size is around ₹9,273 crore, making it one of India’s biggest healthcare IPOs.
• At the upper price band, Manipal Health’s market valuation works out to about ₹77,607 crore.
• Allotment is expected on August 3, 2026. Listing is expected on August 5, 2026, on both BSE and NSE.
• Most of the money raised will be used to repay debt at the hospital’s operating unit.
• Investors should study the company’s financials and risks carefully before applying.

Learn Stock Marketing with a Share Trading Expert! Explore Here!

More about Manipal Health Enterprises

It’s the Manipal Health Enterprises that runs the Manipal Hospitals network. Part of the larger Manipal Group, this group was founded by T. M. A. Pai. Fast forward to today, the company operates a big chain of multi-specialty hospitals across India.

The company offers various types of healthcare services. This includes organ transplants, cancer care, heart care, brain and nerve treatment, bone care, and general preventive health checks.

Over the years, Manipal has grown fast. It has bought several hospital chains like Columbia Asia, AMRI Hospitals, Medica Synergie, Sahyadri Hospitals, and Vikram Hospital in Bengaluru.

With these acquisitions, Manipal has become one of the biggest hospital groups in India, in terms of bed count. This scale is a top reason why investors are excited about the Manipal Health IPO.

Manipal Health IPO: Latest News

Now let’s get into the latest update on the Manipal Health IPO. The company had first filed its draft papers with SEBI in March 2026. SEBI gave its approval in early July 2026. Post the SEBI approval, the company worked on final pricing and dates.

On July 24, 2026, the price band was announced. The IPO will now open for public subscription on July 29, 2026. This is important news for anyone tracking the Manipal Health IPO closely.

Big global investors are linked to this IPO. The key backers of the company are Temasek and Dr Ranjan Pai. There are other investors like TPG and Novo Holdings who also hold stakes. Of these investors, some will sell a portion of their shares through the Offer for Sale (OFS) part of the issue.

It is expected that the Manipal Health IPO will be the second billion-dollar IPO of 2026 in India. The first one was SBI Funds, which raised close to ₹9,813 crore earlier this year.

Manipal Health IPO Date

Let’s look at the exact dates for the Manipal Health IPO:

Mark these dates if you plan to apply. The subscription window is short. Only three days. So, decide early if you want to invest in the Manipal Health IPO.

Manipal Health IPO Price and Lot Size

The price band for the Manipal Health IPO is ₹560 to ₹590 per share. This is the range in which investors can bid.

The minimum lot size is 25 shares. So, a retail investor needs to invest at least ₹14,750 at the upper price band. This is the smallest amount you can put in.

The total issue size is about ₹9,273 crore. This includes a fresh issue of shares worth around ₹8,000 crore. It also includes an Offer for Sale of about ₹1,275 crore.

A fresh issue means the company gets new money for its own use. An OFS means existing shareholders are selling their shares. In this case, promoter and investor entities are selling a part of their holding.

The allocation is split among investor types. Half the shares are set aside for qualified institutional buyers. Retail investors get 35% of the issue. Non-institutional investors get the remaining 15%. Company employees also get a small reserved portion, at a discount to the final price.

Manipal Health IPO GMP

GMP stands for Grey Market Premium. It shows how much extra investors are willing to pay for shares before they list on the stock exchange. It is an unofficial number. But many investors use it as an early signal.

In the days before the official price band was announced, the Manipal Health IPO GMP moved between ₹0 and ₹50. This shows that grey market interest was building slowly.

For the unknown, GMP can change quickly as it depends on market mood, news flow, and overall investor sentiment. A high GMP today does not guarantee a strong listing later. Please do not decide to invest only based on GMP numbers. Always look at the company’s business and financial health too.

Manipal Health IPO Valuation

Valuation is one of the biggest talking points around the Manipal Health IPO. At the upper end of the price band, the company’s market value works out to nearly ₹77,607 crore.

This is actually lower than an earlier reported target. Some early reports had suggested a valuation close to ₹1 lakh crore, or even higher, at around $12-15 billion. However, the company has priced the IPO more conservatively than it was expected earlier.

Despite the number being lower, Manipal Health would still be one of the most valuable listed hospital companies in India. It would feature alongside brands like Apollo Hospitals, Max Healthcare, Fortis Healthcare, and Global Health (Medanta). Investors often make a comparison between Manipal and these companies to judge if the Manipal Health IPO is fairly priced.

Company Financials

Numbers matter a lot when judging any IPO. Let’s take a quick look at Manipal Health’s financial performance.

In 2025, the company reported revenue of about ₹9,409 crore and profit stood at around ₹535 crore. The EBITDA margin, a measure of operating profit, was reported at close to 26.7%. This is a healthy margin for a hospital business.

The company also carries a fair amount of debt. Outstanding borrowings stood at more than ₹10,600 crore as of early 2026 and this is one of the reasons why the company is raising fresh funds.

A big chunk of the new money, close to ₹5,378 crore, will go toward repaying loans at its hospital unit. Another ₹574 crore will be used to buy a bigger stake in its subsidiary, Sahyadri Hospitals.

Bringing down debt should help the company save on interest costs going forward. This could support better profit margins in future years.

Should You Invest in the Manipal Health IPO?

This is the question for which everyone is eagerly waiting for an answer. There is no simple yes or no here as it depends on your goals and risk appetite.

Points in favour:

• Manipal Hospitals is a well-known, trusted healthcare brand in India.
• One of the largest hospital networks in the country.
• The company has strong operating margins.
• Big global investors like Temasek back the business.
• The healthcare sector in India is growing steadily.

Points of caution:

• The company carries a large debt load.
• Healthcare IPOs can list at high valuations, leaving little room for quick listing gains.
• GMP has been modest so far, showing mixed grey market interest.
• Hospital businesses depend on regulation, staffing, and local market conditions, all of which carry some risk.

Many analysts suggest treating the Manipal Health IPO as a long-term investment idea. If you are someone looking for quick listing gains, it may not be the best fit.

On the other hand, if you believe in India’s growing healthcare needs and trust the company’s scale, this IPO may fit your long-term portfolio. It’s better to remain cautious if you are looking for fast profits.

As always, do your own research. Read the official offer documents. Talk to a financial advisor if you are unsure. This is general information and not personal investment advice.

Learn Stock Marketing with a Share Trading Expert! Explore Here!

Conclusion

The Manipal Health IPO is one of the most anticipated listings of 2026. It brings India’s largest hospital network to the stock market. With a price band of ₹560 to ₹590 per share, this issue opens on July 29 and closes on July 31, 2026. The listing is expected on August 5, 2026.

Though the company has strong revenue and healthy margins, it also carries meaningful debt. The Manipal Health IPO GMP has been moderate, not sky-high suggesting that investors should focus on fundamentals rather than short-term listing gains.

Before you apply for the IPO, take ample time and study the company properly. Look beyond the hype and make a decision that fits your own financial goals.